Avricore Health Inc. (AVCRF)

Avricore Health Inc. (ticker AVCRF, US-listed) is a Canadian digital health and telehealth company that develops software and services for remote patient monitoring and management of chronic conditions. The company focuses on delivering cloud-based platforms that connect patients, healthcare providers, and medical professionals to improve health outcomes and reduce healthcare system burden through technology-enabled care delivery.

What the company does

Avricore Health develops digital health software designed to support the management of chronic diseases including heart failure, diabetes, COPD, and hypertension. The company’s technology platform enables remote monitoring of patient vital signs and symptoms, allowing healthcare providers to intervene early when patient status changes. The platform typically integrates with wearable devices, mobile applications, and web-based interfaces to create a connected care ecosystem.

The company’s approach targets both individual healthcare providers and healthcare systems seeking to reduce hospital readmissions, improve patient compliance with treatment regimens, and shift care delivery toward outpatient and home-based settings.

How it makes money

The company generates revenue through subscription-based licensing models where healthcare organizations and provider networks pay recurring fees for access to its remote patient monitoring platform. Revenue typically comes from per-patient monthly or annual subscription fees. The company may also generate revenue through implementation services, training, and technical support provided when healthcare organizations onboard to the platform.

This software-as-a-service (SaaS) model creates predictable recurring revenue while enabling healthcare providers to reduce operational costs associated with managing chronic disease patients.

Market context and industry positioning

The digital health and remote patient monitoring market has grown substantially as healthcare systems face pressure to reduce costs while managing aging populations with increasing rates of chronic disease. Regulatory recognition—including reimbursement for remote patient monitoring under healthcare payment systems—has expanded the addressable market for telehealth and digital health solutions.

Avricore competes in a crowded space that includes both established medical device companies with software divisions and specialized digital health vendors. Differentiation typically comes through ease of integration with existing clinical workflows, quality of clinical data analytics, and ability to demonstrate measurable improvements in patient outcomes or cost savings.

How to research it

Avricore Health’s regulatory filings with the SEC provide the most authoritative source of current information about the business. The company files 10-K annual reports and 10-Q quarterly reports that detail operations, revenue breakdown, customer concentration, competitive landscape, and financial condition.

The company’s official investor relations materials, including press releases and presentations, offer management commentary on business developments. Clinical publications, case studies from deployed installations, and customer testimonials provide evidence of real-world adoption and outcomes. Healthcare industry research reports covering digital health trends and specific vendor evaluations may offer third-party perspective on competitive positioning.